Cart
sales@molnova.com
Bezuclastinib
CAS No. 1616385-51-3
Bezuclastinib( —— )
Catalog No. M35498 CAS No. 1616385-51-3
Bezuclastinib (CGT9486) is a novel, potent and highly selective tyrosine kinase and c-kit D816V inhibitor for the study of advanced mastocytosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 272 | Get Quote |
|
| 5MG | 432 | Get Quote |
|
| 10MG | 692 | Get Quote |
|
| 25MG | 1334 | Get Quote |
|
| 50MG | 2134 | Get Quote |
|
| 100MG | 3321 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBezuclastinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionBezuclastinib (CGT9486) is a novel, potent and highly selective tyrosine kinase and c-kit D816V inhibitor for the study of advanced mastocytosis.
-
DescriptionBezuclastinib (CGT9486) is an orally active, highly selective tyrosine kinase inhibitor with potent activity against KIT D816V. Bezuclastinib can be used for the research of nonadvanced systemic mastocytosis (NonAdvSM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
Targetc-Kit
-
Recptorc-Kit
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1616385-51-3
-
Formula Weight331.37
-
Molecular FormulaC19H17N5O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1[nH]nc(C(=O)Nc2cnc3[nH]c(cc3c2)-c2ccccc2)c1C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Amuvatinib
A novel RTK inhibitor that effectively inhibits c-Kit, PDGFRα and Flt3 with IC50 of 10 nM, 40 nM and 81 nM, respectively.
-
Masitinib
A potent tyrosine kinase inhibitor targeting c-Kit and PDGFR with IC50 of 0.15 and 0.05 uM in cell based assays.
-
AZD2932
AZD2932 is a new series of quinazoline ether inhibitor which potently inhibits VEGFR-2 and PDGFR with IC50s of 4 nM/8 nM/ 7 nM for PDGFRβ/VEGFR-2/Flt-3.
